We hypothesized that SMD with an AD-like pattern of brain atrophy would have worse cognitive performance at baseline, increased neocortical amyloid burden, higher frequency of the APOE ε4 allele, and higher rate of progression to MCI or dementia. The gene discussed is APOE; the disease is dementia.